+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alexion Pharmaceuticals - logo

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases. Alexion developed Soliris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Soliris is approved in more than 50 countries for PNH and more than 40 countries for aHUS. Alexion's company headquarters are based Cheshire, Connecticut, United States.

Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Anemia and Other Blood Disorder Drugs Market Report 2025 - Product Thumbnail Image

Anemia and Other Blood Disorder Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Hypophosphatasia Treatment Market Report 2025 - Product Thumbnail Image

Hypophosphatasia Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Anal Fissure Treatment Market Report 2025 - Product Thumbnail Image

Anal Fissure Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Company Snapshots: US Biotechnology - Product Thumbnail Image

Company Snapshots: US Biotechnology

  • Newsletter
  • July 2025
  • 35 Pages
  • United States
From
Enzyme Replacement Therapy Market Report 2025 - Product Thumbnail Image

Enzyme Replacement Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Paroxysmal Hemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Hemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Global Non-Cancerous Blood Disease Market Analysis 2021-2031 - Product Thumbnail Image

Global Non-Cancerous Blood Disease Market Analysis 2021-2031

  • Report
  • April 2022
  • 307 Pages
  • Global
From
Industry Snapshots: US Biotechnology - Product Thumbnail Image

Industry Snapshots: US Biotechnology

  • Newsletter
  • July 2025
  • 50 Pages
  • United States
From
From
From
Loading Indicator